Table 1: Rheumatology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others
Table 2: Arthritis and Rheumatic Statistics in the United States
Table 3: Rheumatology Drugs Market by Product Type in the US (2014) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others
3. COMPETITIVE LANDSCAPE
Table 4: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others
This report presents Insights into the Rheumatology Drugs Market. Illustrated with 4 data tables, the report comprises of a brief statistical summarization of the worldwide market including US. Also included are global competitive player market shares.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.